Overview

Efficacy and Safety of Colistin Based Antibiotic Therapy

Status:
Enrolling by invitation
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of antibiotic combinations containing Colistin in the treatment of children with multidrug-resistant gram negative infections admitted in the pediatric surgery intensive care unit. The main outcome measure is clinical and microbiological responses to therapy. The secondary outcome is the occurrence of adverse events during Colistin combination treatment.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Ain Shams University
Treatments:
Cilastatin, Imipenem Drug Combination